Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report

R Bec, M Reynaud-Gaubert, F Arnaud, R Naud… - European Journal of …, 2022 - Elsevier
Abstract Rationale and Objectives Cystic fibrosis transmembrane conductance regulator
(CFTR) modulators have revolutionised the treatment of cystic fibrosis (CF). Chest computed …

Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report

R Bec, M Reynaud-Gaubert, F Arnaud… - European Journal of …, 2022 - hal.science
Rationale and objectives: Cystic fibrosis transmembrane conductance regulator (CFTR)
modulators have revolutionised the treatment of cystic fibrosis (CF). Chest computed …

Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report.

R Bec, M Reynaud-Gaubert, F Arnaud… - European Journal of …, 2022 - europepmc.org
Rationale and objectives Cystic fibrosis transmembrane conductance regulator (CFTR)
modulators have revolutionised the treatment of cystic fibrosis (CF). Chest computed …

Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report

R Bec, M Reynaud-Gaubert… - … journal of radiology, 2022 - pubmed.ncbi.nlm.nih.gov
Rationale and objectives Cystic fibrosis transmembrane conductance regulator (CFTR)
modulators have revolutionised the treatment of cystic fibrosis (CF). Chest computed …

Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report

R Bec, M Reynaud-Gaubert, F Arnaud… - European Journal of …, 2022 - ejradiology.com
Abstract Rationale and Objectives Cystic fibrosis transmembrane conductance regulator
(CFTR) modulators have revolutionised the treatment of cystic fibrosis (CF). Chest computed …